Target intelligence / Profile preview

Picornaviral capsid protein VP1 hydrophobic pocket (VP1 pocket)

Target
VP1 pocket
Molecular classification
Viral structural protein, Capsid protein
01

Overview

The picornaviral capsid protein VP1 hydrophobic pocket is a critical structural feature found within the icosahedral shell of viruses in the Picornaviridae family, including rhinoviruses and enteroviruses. This pocket is typically located beneath the floor of a surface depression known as the canyon and is naturally occupied by a fatty acid-like molecule called the pocket factor, which regulates the stability of the viral particle [1][2]. During the infection process, the expulsion of this pocket factor is often a prerequisite for the conformational shifts that lead to viral uncoating and genome release [3]. Therapeutic agents, often referred to as capsid binders or WIN compounds, are designed to occupy this pocket with higher affinity than the natural factor [4]. By filling this cavity, these drugs over-stabilize the capsid, effectively locking it in a state that prevents the release of viral RNA into the host cell cytoplasm [5]. Additionally, drug binding can cause the canyon floor to bulge, potentially interfering with the virus's ability to bind to host cell receptors like ICAM-1 or CD155 [6].

Other names
VP1 hydrophobic cavityWIN pocketCapsid-binding pocketVP1 canyon pocket
02

Mechanism of action

Binding to the hydrophobic pocket stabilizes the viral capsid, preventing the conformational changes required for the release of the viral RNA genome (uncoating) into the host cell. In some cases, drug binding also induces conformational changes in the nearby canyon region, which can sterically hinder the virus from attaching to its cellular receptors.

03

Biological functions

Viral uncoatingViral entryCapsid stabilizationGenome packaging
04

Disease associations

Infection
05

Safety considerations

Rapid emergence of drug-resistant variants due to mutations in the VP1 pocketNarrow spectrum of activity across different picornavirus generaPoor bioavailability for some early-generation compounds
06

Interacting drugs

Pleconaril

5 more in the full profile.

07

Biomarkers

Viral RNA loadViral titerVP1 sequence mutations

Beyond the preview

Go deeper on Picornaviral capsid protein VP1 hydrophobic pocket (VP1 pocket).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Picornaviral capsid protein VP1 hydrophobic pocket (VP1 pocket).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call